Skip to main content
Top
Published in: Annals of Surgical Oncology 13/2020

01-12-2020 | Hepatobiliary Tumors

Predicting Survival in Colorectal Liver Metastasis: Time for New Approaches

Authors: Georgios Antonios Margonis, MD, PhD, Nikolaos Andreatos, MD, Murray F. Brennan, MD

Published in: Annals of Surgical Oncology | Issue 13/2020

Login to get access

Excerpt

Prognostic models are important tools in forecasting survival outcomes. Prognostication facilitates patient–physician discussions and serves as a critical first step in identifying patient subgroups and potentially individuals with a markedly distinct prognosis. Although such prognostic stratification cannot directly predict treatment benefit, it can help to inform clinical decision-making. In trial design, by directing interventions toward appropriate high-risk groups, prognostic indicators can maximize the likelihood of a clinically meaningful trial. Accurate indices often can allow inclusion of patients most likely to benefit and help to reduce trial cohort size. …
Literature
1.
go back to reference Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309–18. (discussion 18–21).CrossRef Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309–18. (discussion 18–21).CrossRef
2.
go back to reference Mahar AL, Compton C, Halabi S, Hess KR, Weiser MR, Groome PA. Personalizing prognosis in colorectal cancer: a systematic review of the quality and nature of clinical prognostic tools for survival outcomes. J Surg Oncol. 2017;116:969–82.CrossRef Mahar AL, Compton C, Halabi S, Hess KR, Weiser MR, Groome PA. Personalizing prognosis in colorectal cancer: a systematic review of the quality and nature of clinical prognostic tools for survival outcomes. J Surg Oncol. 2017;116:969–82.CrossRef
3.
go back to reference Rees M, Tekkis PP, Welsh FK, O’Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg. 2008;247:125–35.CrossRef Rees M, Tekkis PP, Welsh FK, O’Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg. 2008;247:125–35.CrossRef
4.
go back to reference Vauthey JN, Zimmitti G, Kopetz SE, Shindoh J, Chen SS, Andreou A, et al. RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases. Ann Surg. 2013;258:619–26. (discussion 26–7).CrossRef Vauthey JN, Zimmitti G, Kopetz SE, Shindoh J, Chen SS, Andreou A, et al. RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases. Ann Surg. 2013;258:619–26. (discussion 26–7).CrossRef
5.
go back to reference Margonis GA, Spolverato G, Kim Y, Karagkounis G, Choti MA, Pawlik TM. Effect of KRAS mutation on long-term outcomes of patients undergoing hepatic resection for colorectal liver metastases. Ann Surg Oncol. 2015;22:4158–65.CrossRef Margonis GA, Spolverato G, Kim Y, Karagkounis G, Choti MA, Pawlik TM. Effect of KRAS mutation on long-term outcomes of patients undergoing hepatic resection for colorectal liver metastases. Ann Surg Oncol. 2015;22:4158–65.CrossRef
6.
go back to reference Margonis GA, Sasaki K, Gholami S, Kim Y, Andreatos N, Rezaee N, et al. Genetic and morphological evaluation (GAME) score for patients with colorectal liver metastases. Br J Surg. 2018;105:1210–20.CrossRef Margonis GA, Sasaki K, Gholami S, Kim Y, Andreatos N, Rezaee N, et al. Genetic and morphological evaluation (GAME) score for patients with colorectal liver metastases. Br J Surg. 2018;105:1210–20.CrossRef
7.
go back to reference Brudvik KW, Jones RP, Giuliante F, Shindoh J, Passot G, Chung MH, et al. RAS mutation clinical risk score to predict survival after resection of colorectal liver metastases. Ann Surg. 2019;269:120–6.CrossRef Brudvik KW, Jones RP, Giuliante F, Shindoh J, Passot G, Chung MH, et al. RAS mutation clinical risk score to predict survival after resection of colorectal liver metastases. Ann Surg. 2019;269:120–6.CrossRef
8.
go back to reference Paredes A, Hyer, J M, Tsilimigras, D. A novel machine-learning approach to predict recurrence following resection of colorectal liver metastases. Ann Surg Oncol. 2020. (in press). Paredes A, Hyer, J M, Tsilimigras, D. A novel machine-learning approach to predict recurrence following resection of colorectal liver metastases. Ann Surg Oncol. 2020. (in press).
9.
go back to reference Margonis GA, Buettner S, Andreatos N, Kim Y, Wagner D, Sasaki K, et al. Association of BRAF mutations with survival and recurrence in surgically treated patients with metastatic colorectal liver cancer. JAMA Surg. 2018;153:e180996.CrossRef Margonis GA, Buettner S, Andreatos N, Kim Y, Wagner D, Sasaki K, et al. Association of BRAF mutations with survival and recurrence in surgically treated patients with metastatic colorectal liver cancer. JAMA Surg. 2018;153:e180996.CrossRef
10.
go back to reference Ito H, Are C, Gonen M, D’Angelica M, Dematteo RP, Kemeny NE, et al. Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer. Ann Surg. 2008;247:994–1002.CrossRef Ito H, Are C, Gonen M, D’Angelica M, Dematteo RP, Kemeny NE, et al. Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer. Ann Surg. 2008;247:994–1002.CrossRef
11.
12.
go back to reference Margonis GA, Sasaki K, Kim Y, Samaha M, Buettner S, Amini N, et al. Tumor biology rather than surgical technique dictates prognosis in colorectal cancer liver metastases. J Gastrointest Surg. 2016;20:1821–9.CrossRef Margonis GA, Sasaki K, Kim Y, Samaha M, Buettner S, Amini N, et al. Tumor biology rather than surgical technique dictates prognosis in colorectal cancer liver metastases. J Gastrointest Surg. 2016;20:1821–9.CrossRef
13.
go back to reference Forsberg JA, Healey JH, Brennan MF. A probabilistic analysis of completely excised high-grade soft tissue sarcomas of the extremity: an application of a Bayesian belief network. Ann Surg Oncol. 2012;19:2992–3001.CrossRef Forsberg JA, Healey JH, Brennan MF. A probabilistic analysis of completely excised high-grade soft tissue sarcomas of the extremity: an application of a Bayesian belief network. Ann Surg Oncol. 2012;19:2992–3001.CrossRef
14.
go back to reference Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 2002;20:791–6.CrossRef Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 2002;20:791–6.CrossRef
15.
go back to reference Dalal KM, Kattan MW, Antonescu CR, Brennan MF, Singer S. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg. 2006;244:381–91.PubMedPubMedCentral Dalal KM, Kattan MW, Antonescu CR, Brennan MF, Singer S. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg. 2006;244:381–91.PubMedPubMedCentral
16.
go back to reference Kattan MW, Heller G, Brennan MF. A competing-risks nomogram for sarcoma-specific death following local recurrence. Stat Med. 2003;22:3515–25.CrossRef Kattan MW, Heller G, Brennan MF. A competing-risks nomogram for sarcoma-specific death following local recurrence. Stat Med. 2003;22:3515–25.CrossRef
17.
go back to reference Bertsimas D, Dunn J. Optimal classification trees. Mach Learn. 2017;106:1039–82.CrossRef Bertsimas D, Dunn J. Optimal classification trees. Mach Learn. 2017;106:1039–82.CrossRef
Metadata
Title
Predicting Survival in Colorectal Liver Metastasis: Time for New Approaches
Authors
Georgios Antonios Margonis, MD, PhD
Nikolaos Andreatos, MD
Murray F. Brennan, MD
Publication date
01-12-2020
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 13/2020
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-09053-w

Other articles of this Issue 13/2020

Annals of Surgical Oncology 13/2020 Go to the issue